Latest Breaking News On - Veru inc - Page 7 : comparemela.com

Reviewing Sophiris Bio (OTCMKTS:SPHS) and Veru (NASDAQ:VERU)

Reviewing Sophiris Bio (OTCMKTS:SPHS) and Veru (NASDAQ:VERU)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesSophiris bioJamesl heppellVeru incSophiris bio incHealth companyGet free reportFemale health companySophiris bio daily

Veru Reschedules Annual Meeting Of Shareholders

Veru Reschedules Annual Meeting Of Shareholders
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesSamuel fischCorporate communicationsCompany current report on formCompany formVeru incAnnual meetingCurrent reportInternal condomPrivate securities litigation reform actMedia contactInvestor relations

Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High Quality Weight Loss

MIAMI, March 12, 2024 (GLOBE NEWSWIRE) Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innova.

New yorkUnited statesJacobi medical centerSamuel fischSenda biosciencesVersanis bioMitchell steinerLouis aronneEli lillyPresbyterian weill cornell medical centerHenryj kaiser family foundation fellowshipWeill cornell medical collegePfizer incSanfordi weill professor of metabolic researchAmgen incVeru inc

Veru Announces Notification from Nasdaq Related to Delayed

MIAMI, FL, Feb. 27, 2024 (GLOBE NEWSWIRE) Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative.

United statesSamuel fischNasdaq stock marketCompany formVeru incNasdaq hearings panelCorporate communicationsExchange commissionListing qualificationsNasdaq listing ruleQuarterly reportNasdaq listingNasdaq hearingsInternal condomPrivate securities litigation reform actMedia contact

Veru Announces Notification from Nasdaq Related to Delayed Quarterly Report on Form 10-Q

MIAMI, FL, Feb. 27, 2024 Veru Inc. , a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for higher quality weight loss, oncology,.

United statesSamuel fischExchange commissionGlobenewswire incNasdaq stock marketVeru incNasdaq hearings panelCompany formCorporate communicationsListing qualificationsNasdaq listing ruleQuarterly reportNasdaq listingInternal condomPrivate securities litigation reform actMedia contact